Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
1. Purpose
This Executive Order addresses the imposition of ad valorem tariffs in response to the ongoing synthetic opioid crisis linked to the People's Republic of China (PRC), due to the perceived inadequacy of PRC's actions to mitigate the issue.
2. Key Actions And Directives
- Increase Tariff Rate: Amend Executive Order 14195 to increase the tariff rate on specified imports from 10 percent to 20 percent.
- Assert National Emergency: Invoke the International Emergency Economic Powers Act and other legal frameworks to classify the opioid influx as a national security threat.
3. Important Points
- Ad Valorem Tariffs Defined: Tariffs based on the value of imported goods, calculated as a percentage of their value, employed to increase import costs.
- Legal Authority for Tariffs: The President's authority stems from multiple acts including the IEEPA and the National Emergencies Act, allowing increased tariffs in response to national threats.
- Ongoing Drug Crisis: The sustained influx of synthetic opioids, particularly fentanyl, from the PRC is cited as a critical national threat necessitating these tariffs.
- Insufficient PRC Actions: The President asserts that the PRC has taken inadequate measures to combat the illicit production and trafficking of opioids.
- Non-Enforceability Clause: The Executive Order does not create enforceable rights for individuals against the United States, clarifying limits on legal recourse.
Disclaimer: ExecBrief's are AI generated, Please verify with the original source to confirm
Click here to provide feedback to help us improve your experience!
Comments